CGEM logo

Cullinan Oncology (CGEM) EBITDA

Annual EBITDA

-$190.34 M
-$58.30 M-44.15%

December 31, 2023

Summary

Performance

1-Year Change

-44.15%

3-Year Change

-215.79%

5-Year Change

-1208.8%

15-Year Change

-81311.04%

CGEM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.69%
CGEM annual EBITDA is higher than 8.69% of companies in Healthcare sector

High & Low

All-time High

-$36.50 K

3-Year Low

-$190.34 M
CGEM annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CGEM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
CGEM next annual earnings announcement is scheduled for Mar 14, 2025

OtherCGEMprofitabilitymetrics:

Annual Revenue

-
CGEM annual revenue value is unknown

Annual Net Income

-$153.16 M
CGEM annual net profit is -$153.16 million

Annual EBIT

-$190.65 M
CGEM annual earnings before interest & taxes is -$190.65 million

Annual EPS

-$3.69
CGEM annual earnings per share is -$3.69

Quarterly EBITDA

-$48.78 M
+$1.17 M+2.34%

September 30, 2024

Summary

Performance

3-Month Change

+2.34%

1-Year Change

+2.34%

3-Year Change

-165.65%

5-Year Change

-7178.65%

CGEM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.98%
CGEM quarterly EBITDA is higher than 8.98% of companies in Healthcare sector

High & Low

All-time High

$1.40 M
CGEM quarterly EBITDA is currently -3588.20% below its historical high of $1.40 million

3-Year Low

-$62.68 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CGEM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CGEM next earnings announcement is scheduled for Mar 14, 2025

OtherCGEMprofitabilitymetrics:

Quarterly Revenue

-
CGEM quarterly revenue value is unknown

Quarterly Net Income

-$40.56 M
CGEM quarterly net profit is -$40.56 million

Quarterly EBIT

-$48.85 M
CGEM quarterly earnings before interest & taxes is -$48.85 million

Quarterly EPS

-$0.69
CGEM quarterly earnings per share is -$0.69

TTM EBITDA

-$187.05 M
-$4.06 M-2.22%

September 30, 2024

Summary

Performance

3-Month Change

-2.22%

1-Year Change

-2.22%

3-Year Change

-198.21%

5-Year Change

-7345.96%

CGEM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.98%
CGEM TTM EBITDA is higher than 8.98% of companies in Healthcare sector

High & Low

All-time High

$3.76 M
CGEM TTM EBITDA is currently -5078.97% below its historical high of $3.76 million

3-Year Low

-$190.34 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CGEM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CGEM next earnings announcement is scheduled for Mar 14, 2025

OtherCGEMprofitabilitymetrics:

TTM Revenue

-
CGEM TTM revenue value is unknown

TTM Net Income

-$143.54 M
CGEM TTM net profit is -$143.54 million

TTM EBIT

-$187.36 M
CGEM TTM earnings before interest & taxes is -$187.36 million

TTM EPS

-$2.84
CGEM TTM earnings per share is -$2.84

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$190.34 M
CGEM annual EBITDA is -$190.34 million

Annual Net Income

-$153.16 M
CGEM annual net profit is -$153.16 million

Annual Interest Expense

-
CGEM annual interest expense value is unknown

Annual Income Tax

-$14.12 M
CGEM annual income tax is -$14.12 million

Annual D&A

$310.00 K
CGEM annual depreciation & amortization is $310.00 thousand

CGEM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.1%+2.3%-2.2%
3 y3 years-215.8%-165.7%-198.2%
5 y5 years-1208.8%-7178.6%-7346.0%

CGEM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-180.3%at low-63.9%+22.2%-175.5%+1.7%
5 y5-year-757.4%at low-3616.9%+22.2%-7346.0%+1.7%
alltimeall time<-9999.0%at low-3588.2%+22.2%-5079.0%+1.7%

Cullinan Oncology EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$48.78 M(-2.3%)
-$187.05 M(+2.2%)
Jun 2024
-
-$49.95 M(+16.4%)
-$182.99 M(+7.3%)
Mar 2024
-
-$42.91 M(-5.5%)
-$170.57 M(-10.4%)
Dec 2023
-$190.34 M(+44.1%)
-$45.41 M(+1.5%)
-$190.34 M(+7.2%)
Sep 2023
-
-$44.72 M(+19.2%)
-$177.48 M(+9.2%)
Jun 2023
-
-$37.52 M(-40.1%)
-$162.51 M(+0.3%)
Mar 2023
-
-$62.68 M(+92.6%)
-$162.08 M(+22.7%)
Dec 2022
-$132.04 M(+94.5%)
-$32.55 M(+9.4%)
-$132.04 M(-1.3%)
Sep 2022
-
-$29.76 M(-19.8%)
-$133.83 M(+9.3%)
Jun 2022
-
-$37.09 M(+13.6%)
-$122.44 M(+20.1%)
Mar 2022
-
-$32.64 M(-4.9%)
-$101.93 M(+50.1%)
Dec 2021
-$67.90 M(+12.7%)
-$34.34 M(+87.0%)
-$67.90 M(+8.3%)
Sep 2021
-
-$18.36 M(+10.7%)
-$62.72 M(+12.3%)
Jun 2021
-
-$16.59 M(-1296.2%)
-$55.85 M(+4.7%)
Mar 2021
-
$1.39 M(-104.8%)
-$53.36 M(-11.5%)
Dec 2020
-$60.27 M(+171.5%)
-$29.16 M(+153.9%)
-$60.27 M(+67.1%)
Sep 2020
-
-$11.48 M(-18.6%)
-$36.08 M(+50.9%)
Jun 2020
-
-$14.11 M(+155.3%)
-$23.90 M(+153.3%)
Mar 2020
-
-$5.53 M(+11.3%)
-$9.44 M(+275.6%)
Dec 2019
-$22.20 M
-$4.96 M(-820.1%)
-$2.51 M(-180.6%)
DateAnnualQuarterlyTTM
Sep 2019
-
$689.10 K(+90.1%)
$3.12 M(+12.5%)
Jun 2019
-
$362.40 K(-74.1%)
$2.77 M(-26.2%)
Mar 2019
-
$1.40 M(+109.6%)
$3.76 M(+13.4%)
Dec 2018
-$14.54 M(+6120.3%)
-
-
Dec 2018
-
$667.20 K(+94.1%)
$3.31 M(+70.3%)
Sep 2018
-
$343.70 K(-74.5%)
$1.95 M(-22.4%)
Jun 2018
-
$1.35 M(+41.0%)
$2.51 M(+51.5%)
Mar 2018
-
$955.40 K(-236.3%)
$1.66 M(+136.4%)
Dec 2017
-
-$701.00 K(-177.3%)
$700.30 K(-50.0%)
Sep 2017
-
$906.30 K(+83.1%)
$1.40 M(+183.1%)
Jun 2017
-
$495.00 K
$495.00 K
Dec 2016
-$233.80 K(+225.6%)
-
-
Dec 2015
-$71.80 K(-38.2%)
-
-
Dec 2014
-$116.20 K(-82.8%)
-
-
Dec 2013
-$676.80 K(+285.6%)
-
-
Dec 2012
-$175.50 K(+9.2%)
-
-
Dec 2011
-$160.70 K(-80.1%)
-
-
Dec 2010
-$806.50 K(+106.5%)
-
-
Dec 2009
-$390.50 K(+969.9%)
-
-
Dec 2008
-$36.50 K
-
-

FAQ

  • What is Cullinan Oncology annual EBITDA?
  • What is the all time high annual EBITDA for Cullinan Oncology?
  • What is Cullinan Oncology annual EBITDA year-on-year change?
  • What is Cullinan Oncology quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cullinan Oncology?
  • What is Cullinan Oncology quarterly EBITDA year-on-year change?
  • What is Cullinan Oncology TTM EBITDA?
  • What is the all time high TTM EBITDA for Cullinan Oncology?
  • What is Cullinan Oncology TTM EBITDA year-on-year change?

What is Cullinan Oncology annual EBITDA?

The current annual EBITDA of CGEM is -$190.34 M

What is the all time high annual EBITDA for Cullinan Oncology?

Cullinan Oncology all-time high annual EBITDA is -$36.50 K

What is Cullinan Oncology annual EBITDA year-on-year change?

Over the past year, CGEM annual EBITDA has changed by -$58.30 M (-44.15%)

What is Cullinan Oncology quarterly EBITDA?

The current quarterly EBITDA of CGEM is -$48.78 M

What is the all time high quarterly EBITDA for Cullinan Oncology?

Cullinan Oncology all-time high quarterly EBITDA is $1.40 M

What is Cullinan Oncology quarterly EBITDA year-on-year change?

Over the past year, CGEM quarterly EBITDA has changed by +$1.17 M (+2.34%)

What is Cullinan Oncology TTM EBITDA?

The current TTM EBITDA of CGEM is -$187.05 M

What is the all time high TTM EBITDA for Cullinan Oncology?

Cullinan Oncology all-time high TTM EBITDA is $3.76 M

What is Cullinan Oncology TTM EBITDA year-on-year change?

Over the past year, CGEM TTM EBITDA has changed by -$4.06 M (-2.22%)